Spasticity exercises Spasticity is one of the more common symptoms of MS. The condition can range from mild muscle tightness to pain or tightness in and around joints, to uncontrollable spasms of ...

A patient with long-standing multiple sclerosis complains of painful spasms of her lower extremities, associated with electric-like shocks down her spine. What could be the cause and what are the ...

Symptoms of MS may be mild or severe, of long duration or short, and may appear in various combinations, depending on the area of the nervous system affected. Following a relapse, complete or partial ...

December 10, 2009 — Cannabis may be a viable treatment option for some patients with spasticity related to multiple sclerosis (MS), new research suggests. The systematic review, conducted by ...

Selma Blair this week revealed she was once “ridiculed” for attempting to assuage her multiple sclerosis (MS) muscle spasms by bringing a towel into the bath with her. The “Cruel Intentions” actress, ...

Arbaclofen extended-release (ER) reduced spasticity in patients with multiple sclerosis and was found to be safe and well-tolerated, according to 2 new abstracts presented at the 33rd Annual Meeting ...

Flex Pharma, Inc. (NASDAQ: FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments in Phase 2 randomized, controlled trials for cramps and spasticity ...

(HealthDay News) – Smoking cannabis is associated with a reduction in spasticity for patients with multiple sclerosis (MS), according to a study published online May 14 in CMAJ, the journal of the ...

Treatment with the cannabis-based oral spray Nabiximols has been found to significantly relieve spasticity, a common symptom of multiple sclerosis (MS), according to a new analysis of two MS clinical ...

June 28 -- FRIDAY, June 27 (HealthDay News) -- People with multiple sclerosis are at a greater risk than the general population for developing restless legs syndrome (RLS), a new Italian study ...

MARIETTA, Ga.--(BUSINESS WIRE)--Osmotica Pharmaceutical Corp. (privately held), a global specialty pharmaceutical corporation developing best-in-class therapeutics for the treatment of CNS diseases, ...

Credit: Getty Images. The RELEASE MSS1 trial included adults with a confirmed diagnosis of any disease subtype of multiple sclerosis. Topline results were announced from a phase 3 trial evaluating the ...